Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

3.10
BATS BZX Real-Time Price
As of 10:12am ET
 -0.065 / -2.06%
Today’s Change
2.83
Today|||52-Week Range
9.02
-24.14%
Year-to-Date

Today’s Trading

Previous close3.16
Today’s open3.10
Day’s range3.07 - 3.10
Volume13,038
Average volume (3 months)3,493,811
Market cap$409.6M
Dividend yield--
Data as of 10:12am ET, 02/28/2017

Growth & Valuation

Earnings growth (last year)-66.25%
Earnings growth (this year)+12.28%
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)-13.14%
P/E ratioNM
Price/Sales9.86
Price/Book--

Competitors

 Today’s
change
Today’s
% change
COLLCollegium Pharmaceut...-0.31-2.21%
CRBPCorbus Pharmaceutica...-0.10-1.10%
OBSVObseva SA-0.07-0.51%
MYOKMyoKardia Inc-0.15-1.18%
Data as of 10:12am ET, 02/28/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$89.3M
Annual profit (last year)-$148.0M
Net profit margin-165.76%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Richard Peters
Head-
Corporate Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs